In some embodiments, the formulations or compositions described herein have a pH and osmolarity as described herein, and have a concentration of active pharmaceutical ingredient between about 0.01-about 20%, between about 0.01-about 10%, between about 0.01-about 7%, between about 0.01-5%, between about 0.01-about 3%, between about 0.01-about 2% of the active ingredient by weight of the formulation or composition
The product is enhanced by biomimetic peptides that help improve hair regrowth on the scalp
A 2022 scientific review published in the National Library of Medicine confirmed that nasal delivery of therapeutic peptides is a non-invasive and fast-acting method that can effectively bypass the blood-brain barrier while minimising systemic exposure
EMD Millipore) using a Vanquish Flex UHPLC (Thermo Fisher Scientific, Waltham, MA, USA) with buffer A (acetonitrile) and buffer B (20 mM ammonium carbonate, 0.1% ammonium hydroxide, pH 9)